PDGFRB and neoplasm: In order to evaluate the significance of PDGFRβ in prostate cancer, a TMA containing matched non-malignant and tumor tissue from 377 prostate cancer patients with up to 25 year of follow- up was analyzed by PDGFRβ immunohistochemistry.